Abstract
Gene therapy has emerged as a promising strategy for treatment of various diseases. However, widespread implementation is hampered by difficulties in assessing the success of transfection, in particular, the spatial extent of expression in the target tissue and the longevity of expression. Thus, the development of non-invasive reporter techniques based on appropriate molecules and imaging modalities may help to assay gene expression. We now report the design, synthesis and evaluation of a novel in vivo gene transfection reporter molecule 3-O-(β-D-galactopyranosyl)-6- fluoropyridoxol (GFPOL) using fluorinated vitamin B6 as the 19F NMR sensitive aglycone. GFPOL exhibits the following strengths as an in vivo 19F NMR gene expression reporter: (a) large chemical shift response to enzyme cleavage (Δd=8.00 ppm); (b) minimal toxicity for substrate or aglycone; (c) good water solubility; (d) good blood stability; (e) pH responsiveness of aglycone.
Keywords: galactosidase, f nmr, gene reporter, pyridoxol, ph
Medicinal Chemistry
Title: Synthesis and Evaluation of a Novel Gene Reporter Molecule: Detection of b-galactosidase Activity Using 19F NMR of a Fluorinated Vitamin B6 Conjugate+
Volume: 1 Issue: 3
Author(s): Jianxin Yu, Zhenyi Ma, Yingming Li, Kenneth S. Koeneman, Li Liu and Ralph P. Mason
Affiliation:
Keywords: galactosidase, f nmr, gene reporter, pyridoxol, ph
Abstract: Gene therapy has emerged as a promising strategy for treatment of various diseases. However, widespread implementation is hampered by difficulties in assessing the success of transfection, in particular, the spatial extent of expression in the target tissue and the longevity of expression. Thus, the development of non-invasive reporter techniques based on appropriate molecules and imaging modalities may help to assay gene expression. We now report the design, synthesis and evaluation of a novel in vivo gene transfection reporter molecule 3-O-(β-D-galactopyranosyl)-6- fluoropyridoxol (GFPOL) using fluorinated vitamin B6 as the 19F NMR sensitive aglycone. GFPOL exhibits the following strengths as an in vivo 19F NMR gene expression reporter: (a) large chemical shift response to enzyme cleavage (Δd=8.00 ppm); (b) minimal toxicity for substrate or aglycone; (c) good water solubility; (d) good blood stability; (e) pH responsiveness of aglycone.
Export Options
About this article
Cite this article as:
Yu Jianxin, Ma Zhenyi, Li Yingming, Koeneman S. Kenneth, Liu Li and Mason P. Ralph, Synthesis and Evaluation of a Novel Gene Reporter Molecule: Detection of b-galactosidase Activity Using 19F NMR of a Fluorinated Vitamin B6 Conjugate+, Medicinal Chemistry 2005; 1 (3) . https://dx.doi.org/10.2174/1573406053765495
DOI https://dx.doi.org/10.2174/1573406053765495 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Drug Repurposing for the Treatment of Staphylococcal Infections
Current Pharmaceutical Design Pharmacological Modulation of Th17
Recent Patents on Inflammation & Allergy Drug Discovery Role of CHK2 Inhibitors in the Cellular Responses to Ionizing Radiation
Mini-Reviews in Medicinal Chemistry Current Concepts for the Combined Treatment Modality of Ionizing Radiation with Anticancer Agents
Current Pharmaceutical Design The Effects of 1,3,5-trisubstituted Indole Derivatives on Cell Growth, Apoptosis and MMP-2/9 mRNA Expression of MCF-7 Human Breast Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Micro Arrays and Biochips: Applications and Potential in Genomics and Proteomics
Current Genomics miRNAs in Gastrointestinal and Liver Cancers: Their Perspectives and Clinical Applications
Current Pharmaceutical Design Management of Early Stage Cervical Cancer
Reviews on Recent Clinical Trials Embryonic Stem Cells: Overcoming the Immunological Barriers to Cell Replacement Therapy
Current Stem Cell Research & Therapy Targeting Calcium Channels to Block Tumor Vascularization
Recent Patents on Anti-Cancer Drug Discovery Attacking c-Myc: Targeted and Combined Therapies for Cancer
Current Pharmaceutical Design Post-Translational Modification of Transcription Factors: Mechanisms and Potential Therapeutic Interventions
Current Molecular Pharmacology Bombacaceae Between the Ethnomedical Uses and Pharmacological Evidences: A Review
The Natural Products Journal The CLCA Gene Family A Novel Family of Putative Chloride Channels
Current Genomics Melatonin Treatment Combined with TGF-β Silencing Inhibits Epithelial- Mesenchymal Transition in CF41 Canine Mammary Cancer Cell Line
Anti-Cancer Agents in Medicinal Chemistry Hydrogen Sulfide Regulates Intracellular Ca2+ Concentration in Endothelial Cells From Excised Rat Aorta
Current Pharmaceutical Biotechnology Hypoxia as an Initiator of Neuroinflammation: Microglial Connections
Current Neuropharmacology Inhibitors of Nitrogen Oxide Species Production in Animal Models of Inflammation and Future Directions for Therapy in Inflammatory Disorders
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Cancer Stem Cells: The Emerging Challenge of Drug Targeting
Current Medicinal Chemistry Development of A Novel System Based on Green Magnetic / Graphene Oxide / Chitosan /Allium Sativum / Quercus / Nanocomposite for Targeted Release of Doxorubicin Anti-Cancer Drug
Anti-Cancer Agents in Medicinal Chemistry